Severe acute respiratory syndrome (SARS) and coronavirus disease-2019 (COVID-19): From causes to preventions in Hong Kong
Open Access
- 1 May 2020
- journal article
- review article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 94, 156-163
Abstract
No abstract availableKeywords
Funding Information
- Science, Technology and Innovation Commission of Shenzhen Municipality
This publication has 39 references indexed in Scilit:
- Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic StrategiesViruses, 2012
- Avascular osteonecrosis after treatment of SARS: a 3‐year longitudinal studyTropical Medicine & International Health, 2009
- Corticosteroid treatment of severe acute respiratory syndrome in Hong KongJournal of Infection, 2007
- Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)Microbes and Infection, 2006
- Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periodsJournal of Clinical Virology, 2005
- SARS Transmission among Hospital Workers in Hong KongEmerging Infectious Diseases, 2004
- The Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- The SARS epidemic in Hong KongJournal of Epidemiology and Community Health, 2003
- The SARS epidemic in Hong Kong: what lessons have we learned?Journal of the Royal Society of Medicine, 2003
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001